Invivyd IVVD
NASDAQ IVVD
$0.60 +0.02 (+4.01%)
As of: Nov 11, 2026 · 3:59 PM EST

Invivyd (IVVD) Net Margin (2024 - 2026)

Updated

Invivyd (IVVD) recorded Net Margin of -310.77% in Q2 2026, down 186.38 percentage points from -124.38% a year earlier.

Analysis

Invivyd (IVVD) Net Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Invivyd's Net Margin came in at -142.90% as of Jun 30, 2026, up 95.43 percentage points year-over-year; for FY2025, it was -98.27%, up 571.15 percentage points from FY2024.

  • Across earlier years, Net Margin came in at -669.42% in FY2024.
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q3 2024.
  • On a year-over-year basis, Net Margin rose in three of the last four quarters, with an average year-over-year change of +604.63 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Invivyd 168.01 Mn -487.88 Mn 13.01 Mn -310.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -310.77%
Mar 31, 2026 -301.22%
Dec 31, 2025 -64.40%
Sep 30, 2025 -79.75%
Jun 30, 2025 -124.38%
Mar 31, 2025 -144.10%
Dec 31, 2024 -133.45%
Sep 30, 2024 -653.11%
Jun 30, 2024 -2,086.88%
API Access

Invivyd Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY